USAID funding cuts are leading to reduced HIV testing sales and business challenges for companies like Hologic in Africa and China.
3 reports, 1 independent
Updated Jul 24
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
USAID funding cuts are leading to reduced HIV testing sales and business challenges for companies like Hologic in Africa and China.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.USAID cuts are impacting global health business operations in Africa and China.1 source
- Reduced hospital spending and USAID funding cuts impact medical tech sales in Africa and China.
- Lower HIV testing sales in Africa due to USAID funding pauses and procurement issues in China.
Keep exploring
Part of
U.S. cuts to global aid are impacting health programs in South Africa.Also in this story
- South African research shaped global health policies, supported by NIH funding, but Linda-Gail Bekker's center is now facing funding cuts.
- The administration considered funding research into minority crime issues within South Africa.
The entities involved
Coverage
Newest first; wire copies grouped- ZacksHologic's International Momentum Takes Shape: Will Execution Pay Off? International expansion continues to play a central role in Hologic’s HOLX growth strategy. Currently, it generates around 25% of
- Unknown outlet
- Unknown outlet